Turn abandoned patents
into your own filing
into your own filing
This invention describes new chemical compounds called triazines. These compounds are designed to treat diseases caused by inflammation, specifically by blocking how certain sugar-damaged proteins trigger inflammation in blood vessels. They also aim to stop the overgrowth of smooth muscle cells, which contributes to conditions like artery hardening (atherosclerosis) and re-narrowing of blood vessels after surgery (restenosis). The patent focuses on specific triazine structures for these uses.
Why it matters: Filed before advanced computational drug discovery and AI-driven synthesis optimization became prevalent. These tools could now accelerate the identification of optimal triazine compounds or more efficient synthesis routes for treating inflammatory conditions.
AI gives you a few directions you could take this. Pick one, and we check whether your version is different enough to patent, then write the filing.
Reinvent this with AI
